| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Alspaugh Jonathan is a Chief Financial Officer at Spyre Therapeutics, Inc.. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $14.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2022 | SYRE Spyre Therapeutics, Inc. | Chief Financial Officer | Buy | 75,000 | $2.08 | $156,000.00 | +83.0% | -63.5% | -80.9% | |
| Dec 9, 2021 | SYRE Spyre Therapeutics, Inc. | Chief Financial Officer | Buy | 50,000 | $3.72 | $186,000.00 | +123.8% | -35.4% | -89.6% | |
| Aug 18, 2021 | SYRE Spyre Therapeutics, Inc. | Chief Financial Officer | Buy | 40,372 | $6.51 | $262,659.81 | +94.0% | +0.4% | -92.6% |